Patients' access to innovative and expensive medicines and treatments will once again be on the agenda of the informal meeting of EU Health Ministers in Bucharest on Monday 15 April. This theme, initially pushed by the Netherlands in 2016, is still under discussion (see EUROPE B11463A12), but inevitably comes up against the limits of subsidiarity, with large countries showing little interest in a common approach.
The Romanian Presidency of the Council of the EU intends in particular to...